CRRSP1 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
CRRSP1 antibody; At1g61750 antibody; T13M11.11Cysteine-rich repeat secretory protein 1 antibody
Target Names
CRRSP1
Uniprot No.

Target Background

Database Links

KEGG: ath:AT1G61750

UniGene: At.36384

Protein Families
Cysteine-rich repeat secretory protein family
Subcellular Location
Secreted.

Q&A

Given the lack of specific information on "CRRSP1 Antibody" in the search results, I will provide a general framework for FAQs related to antibodies in academic research, focusing on experimental design, data analysis, and methodological considerations. This approach will help researchers navigate common challenges and considerations when working with antibodies.

A:

To validate the specificity of an antibody, consider the following steps:

  • Use multiple controls: Include negative controls (e.g., samples without the target antigen) and positive controls (samples known to contain the target antigen).

  • Assess cross-reactivity: Test the antibody against closely related antigens to ensure it does not cross-react.

  • Use multiple detection methods: Employ techniques like Western blotting, immunofluorescence, and ELISA to confirm specificity across different platforms.

Example:

MethodDescriptionExpected Outcome
Western BlotDetect specific protein bandsClear band at expected molecular weight
ImmunofluorescenceVisualize cellular localizationSpecific staining in expected cellular compartments

A:

  • Quantitative analysis: Use software to quantify band intensities or fluorescence signals.

  • Statistical analysis: Apply appropriate statistical tests to compare groups and assess significance.

  • Consider variability: Account for experimental variability by repeating experiments and using controls.

Example:

SampleBand Intensity (AU)Statistical Significance
Control10 ± 2p < 0.01 vs. Treatment
Treatment20 ± 3

A:

  • Citation and peer review: Choose antibodies cited in peer-reviewed publications.

  • Supplier information: Check the supplier's validation data and recommendations.

  • Experimental validation: Perform in-house validation using relevant controls and detection methods.

Example:

AntibodySupplierCitationsValidation Methods
Anti-CCPCompany A50+Western Blot, ELISA

A:

  • Integrate with proteomics: Use mass spectrometry to validate protein expression levels.

  • Combine with transcriptomics: Correlate antibody data with mRNA expression levels to understand regulation.

  • Use bioinformatics tools: Employ tools like pathway analysis software to integrate data across different omics platforms.

Example:

ProteinmRNA ExpressionAntibody Signal
Protein XHighStrong Signal

A:

  • Re-evaluate experimental conditions: Check for differences in sample preparation, antibody concentrations, or detection methods.

  • Use orthogonal methods: Validate findings with alternative techniques (e.g., PCR for mRNA levels).

  • Consider biological variability: Account for natural variability in biological systems.

Example:

MethodResultPossible Explanation
Western BlotPositiveSpecific detection
ELISANegativeDifferent epitope recognition

A:

  • Specificity issues: Use multiple controls and validate specificity.

  • Batch variability: Ensure consistent antibody batches are used across experiments.

  • Storage conditions: Follow recommended storage conditions to maintain antibody integrity.

Example:

PitfallPrevention Strategy
Specificity IssuesUse multiple controls and validate specificity
Batch VariabilityEnsure consistent batch numbers

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.